Philadelphia PA, June 21, 2021 (GLOBE NEWSWIRE) -- Virion Therapeutics, LLC, developers of T cell-based immunotherapies that utilize the first genetically encoded checkpoint inhibitor, today announced ...
Ocean Biomedical, Inc. (NASDAQ: OCEA) announces that its joint venture partner, Virion Therapeutics, has dosed its first patient in the Phase 1b clinical trial of its investigational VRON-0200 ...
Virion Therapeutics, LLC, a clinical stage biotechnology company, developing novel T cell-based immunotherapies that utilize ...
The Indian vaccine BBV152 is a whole-virion inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine based on Asp614Gly variant and has been formulated with the toll-like ...
PHILADELPHIA, PA—Split-virion—versus subunit—inactivated influenza vaccines provided greater clinical effectiveness among adults ≥50 years of age who sought care for acute respiratory illness during ...
LONDON--(BUSINESS WIRE)--Virion Biotherapeutics announced today the appointments of Vanessa King, PhD, as President & Chief Executive Officer and Isabel Najera, PhD, as Chief Scientific Officer.
The COVID-19 pandemic has led to intensive scientific efforts to bring about an effective vaccine for global distribution. Many different vaccine design approaches are underway. A recent study ...
.Over 8,295 and 821 safety days reported in VRON-0200 alone (n=27), and VRON-0200 combination treated patients (n=7), respectively; VRON-0200 was well tolerated, with no serious treatment-related ...
Scientists have discovered a method to disrupt the production of infectious virus particles that cause hepatitis C, a blood-borne liver disease. This discovery might be a first step in developing new ...
Figure 1: Spontaneous aggregation of purified VSV virions. Figure 4: VSV virion–virion binding in cell culture media, plasma and saliva. Our results indicate that, although virion–virion binding can ...
Two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), and the M2 ion-channel protein are embedded in the viral envelope, which is derived from the host's plasma membrane. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback